No hay productos en el carrito



Bone Drugs in Pediatrics. Efficacy and Challenges
Klein, G.
1ª Edición Abril 2014
Inglés
Tapa dura
233 pags
550 gr
16 x 24 x null cm
ISBN 9781489974358
Editorial SPRINGER
LIBRO IMPRESO
-5%
103,99 €98,79 €IVA incluido
99,99 €94,99 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
ABOUT THIS BOOK
· Presents evidence for the use of certain drugs in the treatment and
prevention of bone loss in children
· Balances the pros and cons of utilizing these drugs in the pediatric
population
· Highlights the potential for future use of these and other drugs with
children
Bone Drugs in Pediatrics brings together in one place the evidence for the use
of certain drugs in the treatment and prevention of bone loss in children, as
well as the reservations still present in the pediatric community regarding
their use. Beginning with a discussion of developmental pharmacokinetics and
drug development for pediatric diseases where bone loss occurs, such as osteogenesis
imperfecta, the physiology of pediatric bone and how best to monitor the safety
and efficacy of these drugs is presented. The pros and cons of utilizing the
drugs themselves – such as bisphosphonates, anti-resorptives and anabolic
agents – within the pediatric population are carefully considered, with
an eye toward safe and effective integration. The potential use of drugs in
future treatment is also highlighted. On the whole, Bone Drugs in Pediatrics
is a cogent presentation of the ongoing debate surrounding the potential for
pharmacological interventions in pediatric bone loss.
Content Level » Professional/practitioner
Keywords » Anti-resorptive - Bisphosphonate - Growth hormone - Oxandralone
- Pediatric bone drugs - Pediatric bone loss - Pediatric pharmacology
Related subjects » Internal Medicine - Orthopedics – Pediatrics
AUTHORS & EDITORS
Gordon L. Klein, MD, MPH, Department of Orthopaedic Surgery, University of Texas Medical Branch, Galveston, TX, USA.
© 2025 Axón Librería S.L.
2.149.0